- Home
- DERM vs RAND Comparison
DERM vs RAND Comparison
Compare DERM & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- RAND
- Stock Information
- Founded
- DERM 2014
- RAND 1969
- Country
- DERM United States
- RAND United States
- Employees
- DERM N/A
- RAND N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- RAND Finance: Consumer Services
- Sector
- DERM Health Care
- RAND Finance
- Exchange
- DERM Nasdaq
- RAND Nasdaq
- Market Cap
- DERM 95.0M
- RAND 80.9M
- IPO Year
- DERM 2021
- RAND N/A
- Fundamental
- Price
- DERM $5.19
- RAND $28.10
- Analyst Decision
- DERM Strong Buy
- RAND
- Analyst Count
- DERM 3
- RAND 0
- Target Price
- DERM $9.50
- RAND N/A
- AVG Volume (30 Days)
- DERM 55.0K
- RAND 17.6K
- Earning Date
- DERM 03-20-2025
- RAND 03-04-2025
- Dividend Yield
- DERM N/A
- RAND 17.90%
- EPS Growth
- DERM N/A
- RAND 123.39
- EPS
- DERM N/A
- RAND 4.98
- Revenue
- DERM $57,771,000.00
- RAND $8,351,941.00
- Revenue This Year
- DERM N/A
- RAND N/A
- Revenue Next Year
- DERM $36.49
- RAND N/A
- P/E Ratio
- DERM N/A
- RAND $5.64
- Revenue Growth
- DERM N/A
- RAND 16.96
- 52 Week Low
- DERM $2.85
- RAND $13.69
- 52 Week High
- DERM $6.89
- RAND $31.89
- Technical
- Relative Strength Index (RSI)
- DERM 60.26
- RAND 78.59
- Support Level
- DERM $4.85
- RAND $22.77
- Resistance Level
- DERM $5.37
- RAND $28.00
- Average True Range (ATR)
- DERM 0.40
- RAND 1.67
- MACD
- DERM 0.02
- RAND 0.42
- Stochastic Oscillator
- DERM 70.49
- RAND 61.64
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, diversified management company. The firm's investment objectives is to maximize the total return to the shareholders with current income combined with capital appreciation. Some of its portfolios include lumious, and GiveGab among others.